(Q33827902)

29 July 2017

1 reference

title

Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment (English)

1 reference

29 July 2017

0 references

Hogue CW Jr

1

1 reference

29 July 2017

Hyder ML

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

The Annals of Thoracic Surgery

29 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 July 2017

volume

69

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

300-306

1 reference

Hazards of postoperative atrial arrhythmias

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Effectiveness of digitalis with or without acebutolol in preventing atrial arrhythmias after coronary artery surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

A perspective of postoperative atrial fibrillation in cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Intraoperative identification of cardiac patients at risk to develop postoperative atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Atrial arrhythmias after cardiothoracic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Atrial fibrillation after coronary artery bypass grafting: a comparison of cardioplegia versus intermittent aortic cross-clamping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

High-density mapping of electrically induced atrial fibrillation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Safety and Rationale for Continuation of Propranolol Therapy During Coronary Bypass Operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Sympathetic-parasympathetic interactions in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Relationship of Atrial Fibrillation to Significant Pericardial Effusion in Valve-replacement Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Electrophysiological properties in chronic lone atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Effect of atrial fibrillation on atrial refractoriness in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Use of constant-infusion verapamil for the treatment of postoperative supraventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

The role of transesophageal echocardiography in the detection of left atrial thrombi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Left atrial thrombi in non-rheumatic atrial fibrillation: assessment of prevalence by transesophageal echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

The promise and problems of meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Beta-blocker effects on postoperative atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: a prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: a prospective, double-blind, randomized, placebo-controlled pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Efficacy of i.v. amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Low-dose amiodarone-related complications after cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Postoperative unilateral pulmonary edema: possible amiodarone pulmonary toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

The cardiac arrhythmia suppression trial (CAST)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Clinical safety profile of sotalol in patients with arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Magnesium sulfate prophylaxis after cardiac operations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Magnesium substitution in elective coronary artery surgery: a double-blind clinical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Thyroid hormone treatment after coronary-artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Antiarrhythmic drugs: a reorientation in light of recent developments in the control of disorders of rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Internal cardioversion of atrial fibrillation in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

Low-energy cardioversion with epicardial wire electrodes: new treatment of atrial fibrillation after open heart surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2901267-9

10.1016/S0003-4975(99)01267-9

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference